Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Br J Haematol ; 145(2): 207-11, 2009 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-19236611

RESUMO

Aprotinin has been used widely in surgery as an anti-bleeding agent but is associated with a number of side effects. We report that textilinin-1, a serine protease inhibitor from Pseudonaja textilis venom with sequence relatedness to aprotinin, is a potent but reversible plasmin inhibitor and has a narrower range of protease inhibition compared to aprotinin. Like aprotinin, textilinin-1 at 5 micromol/l gave almost complete inhibition of tissue plasminogen activator-induced fibrinolysis of whole blood clots. The activated partial thromboplastin time for plasma was markedly increased by aprotinin but unaffected by textilinin-1. In a mouse tail-vein bleeding model, intravenous textilinin-1 and aprotinin caused similar decreases in blood loss but time to haemostasis in the textilinin-treated animals was significantly shorter than in aprotinin-treated mice. Based on these data, textilinin-1 merits further investigation as a therapeutic alternative to aprotinin.


Assuntos
Aprotinina/uso terapêutico , Perda Sanguínea Cirúrgica/prevenção & controle , Venenos Elapídicos/uso terapêutico , Fibrinolisina/antagonistas & inibidores , Inibidores de Serina Proteinase/uso terapêutico , Análise de Variância , Animais , Fibrinólise/efeitos dos fármacos , Hemostasia , Camundongos , Fatores de Tempo
2.
Blood Coagul Fibrinolysis ; 17(5): 417-20, 2006 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-16788320

RESUMO

In-vitro experimentation was performed on porcine and human blood to determine their comparative responsiveness to a novel fibrinolytic inhibitor and thereby assess whether the pig is a suitable animal model for subsequent in-vivo testing of this inhibitor. Thromboelastography showed the clots formed from porcine whole blood to be highly resistant to tissue plasminogen activator (t-PA)-catalyzed lysis, and this communication offers the resistance of porcine plasminogen to activation by t-PA as an explanation. Porcine blood containing 100 and 1500 IU/ml added t-PA lysed very slowly, having LY30 values of 1.9 +/- 1.4 and 2.9 +/- 1.9%, respectively. In contrast, the LY30 values for the human clots containing 100 and 1500 IU/ml t-PA were 77.1 +/- 6.3 and 93.3 +/- 1.3%, respectively. Moreover, purified porcine plasminogen was activated very slowly by added t-PA in the presence of both human and porcine fibrin. Activation of plasminogen by the endogenous activators, as measured by the euglobulin clot lysis time, was greatly prolonged for the pig (22 +/- 3 h) compared with the human (3.5 +/- 1.5 h). These results suggest caution in using the pig as an experimental model when studying the effects of various agents on fibrinolysis.


Assuntos
Fibrinólise/efeitos dos fármacos , Fibrinolíticos/farmacologia , Trombose/prevenção & controle , Ativador de Plasminogênio Tecidual/uso terapêutico , Animais , Ativação Enzimática/efeitos dos fármacos , Ativação Enzimática/fisiologia , Fibrinolíticos/metabolismo , Humanos , Modelos Animais , Plasminogênio/metabolismo , Proteínas Recombinantes/farmacologia , Soroglobulinas/química , Soroglobulinas/metabolismo , Suínos , Tromboelastografia , Ativador de Plasminogênio Tecidual/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...